Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide add-on to levetiracetam with withdrawal of concomitant sodium channel blocker in adults with uncontrolled partial-onset seizures
NL-OMON37460Phase 3Withdrawn
- Sponsor
- UCB
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lacosamide in epilepsy, Focal onset seizure, sponsored by UCB. Planned start Mar 2012; status: withdrawn.
02
Drugs
lacosamide
03
Conditions
epilepsyFocal onset seizure
Beyond the preview
Go deeper on NL-OMON37460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37460.